마이크로캐리어 시장 규모, 점유율, 동향 분석 보고서 : 소모품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Microcarriers Market Growth & Trends:

The global microcarriers market size is expected to reach USD 3.50 billion by 2030, registering a CAGR of 10.49% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is driven by the rising demand of cell-cultured products, the growing burden of diseases worldwide, constant investments for intensive R&D activities to identify and develop new treatments for rare disorders, and the continuous developments in technologies employed in advanced research such as cell-biology.4

Amidst the COVID-19 pandemic, the market witnessed a positive growth. The continuous strive of scientist and researchers to find and develop vaccines for the SARS-CoV2 virus resulted in scaling up of R&D efforts by both healthcare companies and academic institutes. The increased research activities, huge funding, and growing demand of therapeutic products resulted in the growth of the market. Moreover, development of viral vectors based vaccines requires efficient production of viruses which is possible using microcarriers cell-culture. For instance, scientists from University of Copenhagen demonstrated in their research article published in June 2021 that SARS-CoV2 virus was efficiently produced in Vero cells in a single-use bioreactors packed with carrier beads. Findings like these have boosted the COVID-19 vaccine production further propelling market growth.

Moreover, the marketspace is rapidly expanding owing to the high usage of microcarriers as matrix for adherent cell manufacturing and these small spherical beads are used across all scales of commercial production. The increasing demand of innovative therapeutic options such as cell and gene therapy, viral vaccines, and monoclonal antibodies for treatment of malignant and rare diseases has resulted in increase in the biopharmaceutical production capacities. For example, Pfizer Inc., announced in December 2021 that it has invested USD 68.5 million and opened a new facility in North Carolina, USA. With the expansion the company is focused on enhancing its gene therapy capabilities and clinically develops its portfolio for hemophilia A and B, DMD (Duchenne muscular dystrophy), ALS (amyotrophic lateral sclerosis) and many more neurologic, endocrine as well as metabolic diseases. Such increased investments for development of biopharmaceuticals and regenerative medicines are expected to propel the market growth.

Furthermore, cell-biology based research involves exhaustive R&D for developing new therapies. But these efforts require investments for cell lines, media, equipment and other related products for microcarriers culture and thus requires huge influx of money. Institutes and emerging players with budget constraints will limit the cell based research for therapeutics development. Hence, it will decrease the adoption of cell-culture products and restrain the growth. However, government initiatives for novel drug production and collaboration & partnerships with key players can offer investment relief and enhance the market growth.

Microcarriers Market Report Highlights:

• By consumables, microcarrier beads was identified as the larger contributor with 64.46% share in 2024. The ever-expanding use of microcarrier beads during cell culture contributes to the highest revenue generation in the market.
• By application, the biopharmaceutical production segment captured the largest market share 71.81%, in 2024, due to the growing cases of infectious diseases & genetic disorders and increasing cancer incidence, resulting in increasing demand for producing safe & effective medicines or treatments.
• The pharmaceutical & biotechnology companies segment captured the largest market share at 43.95% in 2024 and is anticipated to grow significantly over the forecast period.
• North America generated the highest revenue with a 41.11% share in 2024. The area is witnessing a surge in chronic and infectious diseases, necessitating advanced medical treatments
• Asia Pacific region is primarily influenced by the increasing demand for biologics within its domestic market and the growth of its economies, alongside having the highest population of seniors

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definition
  • 1.2.1. Consumable
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
• 1.7. Primary Research
• 1.8. Information or Data Analysis
• 1.9. Market Formulation & Validation
• 1.10. Market Model
• 1.11. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Microcarriers Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. High demand of cell based vaccines & therapeutics
    • 3.2.1.2. Increasing incidence of various diseases & disorders
    • 3.2.1.3. Huge investments for development of innovative therapies
    • 3.2.1.4. Consistent technological advancements in cell biology research
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of research for cell based drug and therapy
    • 3.2.2.2. High cost of downstream processing
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis

Chapter 4. Microcarriers Market: Consumable Estimates & Trend Analysis

• 4.1. Consumable Movement Analysis & Market Share, 2024 & 2030
• 4.2. Microcarriers Market Estimates & Forecast, By Consumable, 2018 to 2030 (USD Million)
• 4.3. Media and Reagents
  • 4.3.1. Media and Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Microcarrier Beads
  • 4.4.1. Microcarrier Beads Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Collagen Coated Beads
    • 4.4.2.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Cationic Beads
    • 4.4.3.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Protein Coated Beads
    • 4.4.4.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.5. Untreated Beads
    • 4.4.5.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.6. Others
    • 4.4.6.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Microcarriers Market: Application Estimates & Trend Analysis

• 5.1. Application Movement Analysis & Market Share, 2024 & 2030
• 5.2. Microcarriers Market Estimates & Forecast, By Consumable, 2018 to 2030 (USD Million)
• 5.3. Biopharmaceutical Production
  • 5.3.1. Biopharmaceutical Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.2. Vaccine Production
    • 5.3.2.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.3. Therapeutic Production
    • 5.3.3.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Regenerative Medicine
  • 5.4.1. Regenerative Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Microcarriers Market: End Use Estimates & Trend Analysis

• 6.1. End Use Movement Analysis & Market Share, 2024 & 2030
• 6.2. Microcarriers Market Estimates & Forecast, By Consumable, 2018 to 2030 (USD Million)
• 6.3. Pharmaceutical & Biotechnology Companies
  • 6.3.1. Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. CROs & CMOs
  • 6.4.1. CROs & CMOs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Academic & Research Institutes
  • 6.5.1. Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Microcarriers Market: Regional Estimates & Trend Analysis by Consumable, Application and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Regulatory framework
    • 7.3.4.3. Competitive scenario
    • 7.3.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Regulatory framework
    • 7.4.9.3. Competitive scenario
    • 7.4.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. Australia
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. South Korea
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Vendor Landscape
  • 8.2.1. Key company market share analysis, 2024
  • 8.2.2. Thermo Fisher Scientific, Inc.
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Merck KGaA
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Danaher Corporation
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Sartorius AG
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Corning Incorporated
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Eppendorf SE
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Bio-Rad Laboratories, Inc.
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. HiMedia Laboratories Pvt. Ltd.
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. DenovoMATRIX GmbH
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives